Accès libre

Biological treatment in chronic rhinosinusitis with nasal polyposis

   | 03 mars 2022
À propos de cet article


1. Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 20161;6 Suppl 1:S22-209. DOI: 10.1002/alr.21695.10.1002/alr.2169526889651 Search in Google Scholar

2. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. DOI: 10.4193/Rhin20.600.10.4193/Rhin20.60032077450 Search in Google Scholar

3. Fokkens W, Van Der Lans R, Reitsma S. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis. Expert Opin Biol Ther. 2021;21(5):575-85. DOI: 10.1080/14712598.2021.1901881.10.1080/14712598.2021.190188133724109 Search in Google Scholar

4. Chaskes MB, Kong KA, Senior B. Biologic therapy for the treatment of chronic rhinosinusitis with nasal polyposis: An update and review of the literature. Eur J Rhinol Allergy. 2021;4(3):72-6.10.5152/ejra.2021.21050 Search in Google Scholar

5. Kartush AG, Schumacher JK, Shah R, Patadia MO. Biologic agents for the treatment of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33(2):203-11. DOI: 10.1177/1945892418814768.10.1177/194589241881476830587005 Search in Google Scholar

6. Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J of Otolaryngol – Head & Neck Surg. 2021;50(1):15. DOI: 10.1186/s40463-021-00493-2.10.1186/s40463-021-00493-2794530033750471 Search in Google Scholar

7. Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on 4biologics for CRSwNP with or without asthma. Allergy. 2019;74(2):2312-9. DOI: 10.1111/all.13875.10.1111/all.13875697298431090937 Search in Google Scholar

8. Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337-53. DOI: 10.1111/all.14809.10.1111/all.1480933683704 Search in Google Scholar

9. Bachert C, Desrosiers MY, Hellings PW, Laidlaw TM. The role of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(3):1099-106. DOI: 10.1016/j.jaip.2020. Search in Google Scholar

10. Peters AT, Han JK, Hellings P, Heffler E, Gevaert P, Bachert C, et al. Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(6):2461-2471.e5. DOI: 10.1016/j.jaip.2021. Search in Google Scholar